Early Foley Catheter Removal After Diverticular Colovesical Fistula Repair

February 19, 2026 updated by: Karim Alavi
Patients undergoing surgical repair of colovesical fistula will have have "early" (post-operative day 3) cystogram and removal of bladder catheter. Outcomes from the "early" group will be compared to historical "late" group data to determine if early bladder catheter removal is safe.

Study Overview

Detailed Description

There is defined time for foley/bladder catheter removal after colovesical fistula repair in the current surgical literature. This study will be a prospective cohort study evaluating outcomes after early foley catheter removal (on post-operative day 3), specifically bladder leak, 30-day readmissions and adverse events. This cohort will be compared to a retrospective "late" group, who had foley catheter removal later in their hospital course.

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Worcester, Massachusetts, United States, 01605
        • UMass Memorial Medical Center Memorial Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18 and over
  • Undergoing surgical repair of diverticular colovesical fistula

Exclusion Criteria:

  • Patients with active and untreated genitourinary cancers
  • Subjects with known or suspected Inflammatory Bowel Disease as the cause of colovesical fistula.
  • Individuals who are not expected to regain normal bladder function after surgery as defined by either pre-existing bladder dysfunction with chronic indwelling urinary catheter, supra-pubic catheter, or surgical urinary diversion
  • Individuals who require re-operation prior to Foley removal
  • Adults unable to consent
  • Pregnant women
  • Prisoners
  • Individuals who are not yet adults (infants, children, teenagers less than 18 years old)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Foley catheter removal day 2 or 3 post-operative procedure
According to review of internal clinical practices, the average duration of catheterization after Colovesical Fistula (CVF) repair is 10.8 days after CVF repair. The intervention in this study removes the Foley Catheter at 2 to 3 days post CVF repair.
According to review of internal clinical practices, the average duration of catheterization after Colovesical Fistula (CVF) repair is 10.8 days after CVF repair. The intervention in this study removes the Foley Catheter at 2 to 3 days post CVF repair.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of positive urine leak on post-operative day 3 cystogram
Time Frame: up to 3 days post surgery
Participants cystograms will be reviewed to detect positive urine leak, 2 to 3 days post surgery.
up to 3 days post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foley catheter re-insertion
Time Frame: up to 5 days post-surgery
Participants who will require re-insertion of the foley catheter once it is removed on post-operative day 3
up to 5 days post-surgery
Re-operations within 30 days of initial surgery
Time Frame: up to 30 days post discharge
Patients who have required return to the OR within 30 days after discharge.
up to 30 days post discharge
Hospital re-admission
Time Frame: up to 30 days post- discharge
Patients who have required readmission to the hospital within 30 days after discharge.
up to 30 days post- discharge
Symptomatic post-operative urinary tract infection
Time Frame: up to days post discharge
Patients who have had a symptomatic urinary tract infection within 30 days after discharge.
up to days post discharge
Post operative urinary sepsis
Time Frame: up to 30 days post discharge
Patients who have urinary sepsis either prior to discharge or within 30 days after discharge.
up to 30 days post discharge
Recurrence of colovesical fistula
Time Frame: up to 30 days post-discharge
Patients who had recurrence of their colovesical fistula within 30 days of discharge.
up to 30 days post-discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: KArin Alavi, MD, MPH, UMass Chan Medical School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2019

Primary Completion (Actual)

January 31, 2026

Study Completion (Actual)

January 31, 2026

Study Registration Dates

First Submitted

December 16, 2021

First Submitted That Met QC Criteria

February 10, 2022

First Posted (Actual)

February 11, 2022

Study Record Updates

Last Update Posted (Actual)

February 20, 2026

Last Update Submitted That Met QC Criteria

February 19, 2026

Last Verified

June 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colovesical Fistula

Subscribe